GuangYuYuan Chinese Herbal Medicine Co., Ltd.'s (SHSE:600771) Business Is Yet to Catch Up With Its Share Price

When you see that almost half of the companies in the Pharmaceuticals industry in China have price-to-sales ratios (or "P/S") below 3.4x, GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHSE:600771) lo

Simply Wall StMay 1 08:45

Guang Yuyuan (600771.SH) announced first-quarter results, net profit of 41.3036 million yuan, a year-on-year increase of 49.61%

Guang Yuyuan (600771.SH) released its report for the first quarter of 2024, with revenue of 343 million yuan, compared with...

Zhitong FinanceApr 30 00:22

Guang Yuyuan (600771.SH) and related personnel received the “Administrative Penalty Decision” and the “Market Ban Decision”

Guang Yuyuan (600771.SH) announced that on April 10, 2024, the company and relevant parties received the “Administrative Penalty Decision” and “Market Ban Decision” issued by the Shanxi Regulatory Bureau (“Shanxi Securities Regulatory Bureau”) of the China Securities Regulatory Commission.

Zhitong FinanceApr 11 07:03

Express News | Guang Yuyuan: Received the “Administrative Penalty Decision” and the “Market Ban Decision”

BreakingsApr 10 23:20

Express News | Guang Yuyuan: Director Zhang Bin and director and CEO Miao Hui resign.

BreakingsApr 10 09:05

Zhang Bin, director of Guang Yuyuan (600771.SH), and Miao Hui, director and president, resign

Guang Yuyuan (600771.SH) issued an announcement. The board of directors of the company recently received written resignation reports from director Zhang Bin and director and president Mr. Miao Hui. Mr. Zhang Bin applied to resign as a director of the company due to personal reasons. After his resignation, Mr. Zhang Bin no longer held any position in the company. Due to personal reasons, Mr. Miao Hui applied to resign as the company's president, director, and member of the Remuneration and Assessment Committee. After his resignation, Mr. Miao Hui no longer held any position in the company.

Zhitong FinanceApr 9 19:32